Building the Future of RNA Manufacturing
Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?
False
Can enzyme-catalyzed processes address the limitations of traditional RNA synthesis and define the future of scalable, sustainable manufacturing of RNA therapeutics?
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
November 2, 2026
2 min read
Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification
October 22, 2026
5 min read
Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner
October 21, 2026
6 min read
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
July 14, 2026
3 min read
Researchers retrofit a lab-scale monoclonal antibody purification platform with automation, OPC-UA connectivity, and model-based flow control
False
Affiliations:
Specialties:
Areas of Expertise: